Cambridge Cognition Ltd Aims to Transform Neurological Care Through Tablet-Based Cognitive Assessment

Published: Sep 08, 2011

HELSINKI--(BUSINESS WIRE)--Leading UK developer of neuropsychological tests for the pharmaceutical industry and research institutions, Cambridge Cognition, today announces plans to launch a range of touch-screen mobile (tablet-based) cognitive assessments for doctors to use with their patients at every stage of life. First to market within the next 12 months will be an iPad GP version of their well-established PAL memory test to aid early detection of Alzheimer’s disease.

Back to news